PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 14 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Administration of A. dracunculus (1000 mg twice daily for 90 days) resulted in significant decreases in systolic blood pressure [PMID:27097076]
Ethanolic extract (PMI5011) improved fatty acid oxidation, metabolic flexibility in skeletal muscle, reduced insulin levels, and decreased ectopic lipid accumulation in the liver and skeletal muscle [PMID:29476602]
PMI5011 at 30 μg/mL significantly increases osteogenic gene expression [PMID:37686232]
Safety & adverse effects
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 18555848 (2008) — Strategies for assessment of botanical action on metabolic syndrome in the mouse and evidence for a genotype-specific effect of Russian tarragon in the regulation of insulin sensitivity. · Metabolism: clinical and experimental
- 2.PMID: 37686232 (2023) — Extract of Artemisia dracunculus L. Modulates Osteoblast Proliferation and Mineralization. · International journal of molecular sciences
- 3.PMID: 28729836 (2017) — An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes. · Frontiers in pharmacology
- 4.PMID: 29476602 (2018) — An Extract of Russian Tarragon Prevents Obesity-Related Ectopic Lipid Accumulation. · Molecular nutrition & food research
- 5.PMID: 31815461